BioCentury
ARTICLE | Clinical News

CP024: Interim Phase I data

September 12, 2011 7:00 AM UTC

Interim data from a Phase I trial in healthy volunteers showed that intranasal CP024 produced insulin-like growth factor-1 (IGF-I) levels comparable to that of a subcutaneous injection of an undisclos...